Partnerships

The right patients change everything

TESA Research collaborates with biopharma, diagnostic, and academic partners. We bring computational expertise, an adaptable platform, and a team that understands both the science and the implementation path.

How we partner

Work with TESA Research

Trial enrichment

Improve ongoing programs

We support active pharma and biotech trials by identifying biomarkers that separate responders from non-responders, dramatically improving the odds of a positive readout.

Asset rescue

Revisit halted assets

Many drugs fail on endpoints, due to incorrect patient population rather than safety concerns. We partner on discontinued assets to identify the patient subgroups with high response potential.

Discovery

Biomarker-driven discovery

We work with partners to systematically uncover biomarkers that open new development paths in well-defined patient subgroups.

What we bring

A partner that delivers

Our founding team built genomic-interpretation software used in hundreds of clinical labs worldwide. We know how to move from algorithm to action.

  • Platform-agnostic inputs. We work with the data you already generate, any platform, liquid or tumor biopsy.
  • Whole-architecture analysis. Genome-wide structural patterns other platforms discard are our core signal.
  • DNA-only deployment. Once trained, classification of new patients requires only DNA, a practical path into clinical workflows.
  • A proven implementation team. Decades of experience turning complex genomic data into tools clinicians actually use.
Academic collaborations

Working with leading scientists

Our platform has been validated in multiple active collaborations with internationally recognized cancer researchers at Dana Farber Cancer Institute, University of Southampton, and early-stage BioPharma company.

Next step

Let's look at your data

Whether you're validating new drug targets, exploring patient cohorts, or enhancing clinical assay performance, our tools can help.